TW200413286A - Novel functional peptide nucleic acid and process for producing the same - Google Patents

Novel functional peptide nucleic acid and process for producing the same Download PDF

Info

Publication number: TW200413286A
Authority: TW; Taiwan
Prior art keywords: functional; molecules; pna; amino acid; cbz
Prior art date: 2002-11-19

Application number

TW092131450A

Other languages

English (en)

Chinese (zh)

Inventor

Fumihiko Kitagawa

Hisafumi Ikeda

Original Assignee

Fumihiko Kitagawa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-19

Filing date

2003-11-11

Publication date

2004-08-01

2003-11-11 Application filed by Fumihiko Kitagawa filed Critical Fumihiko Kitagawa

2004-08-01 Publication of TW200413286A publication Critical patent/TW200413286A/zh

Links

238000000034 method Methods 0.000 title claims abstract description 92
230000008569 process Effects 0.000 title claims abstract description 12
108091093037 Peptide nucleic acid Proteins 0.000 title abstract description 10
150000001875 compounds Chemical class 0.000 claims abstract description 67
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 claims abstract description 15
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 14
238000010511 deprotection reaction Methods 0.000 claims abstract description 12
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims abstract description 12
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims abstract description 10
125000006239 protecting group Chemical group 0.000 claims abstract description 9
238000005520 cutting process Methods 0.000 claims abstract description 8
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims abstract description 7
229930024421 Adenine Natural products 0.000 claims abstract description 7
229960000643 adenine Drugs 0.000 claims abstract description 7
229940104302 cytosine Drugs 0.000 claims abstract description 7
239000011347 resin Substances 0.000 claims abstract description 7
229920005989 resin Polymers 0.000 claims abstract description 7
229940113082 thymine Drugs 0.000 claims abstract description 6
238000006243 chemical reaction Methods 0.000 claims description 24
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 claims description 20
239000012528 membrane Substances 0.000 claims description 19
239000007790 solid phase Substances 0.000 claims description 18
239000003795 chemical substances by application Substances 0.000 claims description 17
238000004519 manufacturing process Methods 0.000 claims description 17
230000035699 permeability Effects 0.000 claims description 15
-1 HABA Chemical compound 0.000 claims description 14
150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 14
238000009833 condensation Methods 0.000 claims description 14
230000005494 condensation Effects 0.000 claims description 14
238000003786 synthesis reaction Methods 0.000 claims description 13
229920000642 polymer Polymers 0.000 claims description 11
230000015572 biosynthetic process Effects 0.000 claims description 10
239000002253 acid Substances 0.000 claims description 8
150000001413 amino acids Chemical class 0.000 claims description 7
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 7
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 7
ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 7
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
210000000056 organ Anatomy 0.000 claims description 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
125000003277 amino group Chemical group 0.000 claims description 5
210000001541 thymus gland Anatomy 0.000 claims description 5
XBNGYFFABRKICK-UHFFFAOYSA-N 2,3,4,5,6-pentafluorophenol Chemical compound OC1=C(F)C(F)=C(F)C(F)=C1F XBNGYFFABRKICK-UHFFFAOYSA-N 0.000 claims description 4
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
230000018044 dehydration Effects 0.000 claims description 4
238000006297 dehydration reaction Methods 0.000 claims description 4
230000003287 optical effect Effects 0.000 claims description 4
IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachloro-phenol Natural products OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 claims description 4
239000012071 phase Substances 0.000 claims description 4
150000003254 radicals Chemical group 0.000 claims description 4
WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 claims description 3
239000007821 HATU Substances 0.000 claims description 3
230000000844 anti-bacterial effect Effects 0.000 claims description 3
238000004132 cross linking Methods 0.000 claims description 3
230000002165 photosensitisation Effects 0.000 claims description 3
239000003504 photosensitizing agent Substances 0.000 claims description 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 6
229960000956 coumarin Drugs 0.000 claims 3
235000001671 coumarin Nutrition 0.000 claims 3
229910052762 osmium Inorganic materials 0.000 claims 2
SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims 2
BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims 2
238000005054 agglomeration Methods 0.000 claims 1
230000002776 aggregation Effects 0.000 claims 1
JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical class C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 claims 1
GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims 1
125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
238000000926 separation method Methods 0.000 claims 1
239000002689 soil Substances 0.000 claims 1
238000006467 substitution reaction Methods 0.000 claims 1
230000002194 synthesizing effect Effects 0.000 abstract description 7
239000000178 monomer Substances 0.000 description 56
239000002243 precursor Substances 0.000 description 26
210000004027 cell Anatomy 0.000 description 15
239000000523 sample Substances 0.000 description 12
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
238000005516 engineering process Methods 0.000 description 8
238000001308 synthesis method Methods 0.000 description 8
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 6
108090000790 Enzymes Proteins 0.000 description 6
210000000170 cell membrane Anatomy 0.000 description 6
238000003776 cleavage reaction Methods 0.000 description 5
238000006482 condensation reaction Methods 0.000 description 5
230000007017 scission Effects 0.000 description 5
238000010532 solid phase synthesis reaction Methods 0.000 description 5
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical class O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 5
GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 4
108020004707 nucleic acids Proteins 0.000 description 4
150000007523 nucleic acids Chemical class 0.000 description 4
102000039446 nucleic acids Human genes 0.000 description 4
IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 4
ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 4
239000003021 water soluble solvent Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
150000007933 aliphatic carboxylic acids Chemical class 0.000 description 3
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
238000013461 design Methods 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
229930195733 hydrocarbon Natural products 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
AOCSUUGBCMTKJH-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCN AOCSUUGBCMTKJH-UHFFFAOYSA-N 0.000 description 3
238000005406 washing Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
101710120040 Antifungal peptide Proteins 0.000 description 2
108050004290 Cecropin Proteins 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
239000004365 Protease Substances 0.000 description 2
UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 2
230000000692 anti-sense effect Effects 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
230000014509 gene expression Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000000762 glandular Effects 0.000 description 2
238000004128 high performance liquid chromatography Methods 0.000 description 2
150000007857 hydrazones Chemical class 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
239000000463 material Substances 0.000 description 2
GSYSFVSGPABNNL-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-(phenylmethoxycarbonylamino)acetate Chemical group COC(=O)C(P(=O)(OC)OC)NC(=O)OCC1=CC=CC=C1 GSYSFVSGPABNNL-UHFFFAOYSA-N 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000001568 sexual effect Effects 0.000 description 2
239000007787 solid Substances 0.000 description 2
229960002317 succinimide Drugs 0.000 description 2
239000013076 target substance Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
XVXJCXAYRINQBW-UHFFFAOYSA-N 5-aminopentane-1,2,3-triol Chemical group NCCC(O)C(O)CO XVXJCXAYRINQBW-UHFFFAOYSA-N 0.000 description 1
RUFDYIJGNPVTAY-UHFFFAOYSA-N 6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound CC(C)(C)OC(=O)NCCCCCC(O)=O RUFDYIJGNPVTAY-UHFFFAOYSA-N 0.000 description 1
HJENAZQPOGVAEK-UHFFFAOYSA-N 7-[(2-methylpropan-2-yl)oxycarbonylamino]heptanoic acid Chemical compound CC(C)(C)OC(=O)NCCCCCCC(O)=O HJENAZQPOGVAEK-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
108010006654 Bleomycin Proteins 0.000 description 1
241000255789 Bombyx mori Species 0.000 description 1
ZTQNECFPCYNOQY-UHFFFAOYSA-N COC12C(C=CC=C1)S2 Chemical compound COC12C(C=CC=C1)S2 ZTQNECFPCYNOQY-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
241000269333 Caudata Species 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
238000000018 DNA microarray Methods 0.000 description 1
PXXNTAGJWPJAGM-VCOUNFBDSA-N Decaline Chemical compound C=1([C@@H]2C3)C=C(OC)C(OC)=CC=1OC(C=C1)=CC=C1CCC(=O)O[C@H]3C[C@H]1N2CCCC1 PXXNTAGJWPJAGM-VCOUNFBDSA-N 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
241000015864 Protobothrops flavoviridis Species 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
150000003862 amino acid derivatives Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
229960001561 bleomycin Drugs 0.000 description 1
OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
125000002843 carboxylic acid group Chemical group 0.000 description 1
210000004720 cerebrum Anatomy 0.000 description 1
239000013522 chelant Substances 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000002224 dissection Methods 0.000 description 1
230000005611 electricity Effects 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical group [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000001215 fluorescent labelling Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
230000008676 import Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
229960005375 lutein Drugs 0.000 description 1
KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004879 molecular function Effects 0.000 description 1
239000003147 molecular marker Substances 0.000 description 1
VQOXZBDYSJBXMA-RKEBNKJGSA-N nystatin a1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@@H]1OC1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)CC(O)CC(O)CC(O)CCC(O)C(O)C[C@](O)(CC(O)C2C(O)=O)OC2C1 VQOXZBDYSJBXMA-RKEBNKJGSA-N 0.000 description 1
230000037361 pathway Effects 0.000 description 1
125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
150000003141 primary amines Chemical group 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
239000005871 repellent Substances 0.000 description 1
238000011160 research Methods 0.000 description 1
238000005070 sampling Methods 0.000 description 1
239000000344 soap Substances 0.000 description 1
238000011425 standardization method Methods 0.000 description 1
230000003068 static effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
108010032153 thanatin Proteins 0.000 description 1
150000003568 thioethers Chemical class 0.000 description 1
230000002992 thymic effect Effects 0.000 description 1
KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
238000001890 transfection Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
230000009278 visceral effect Effects 0.000 description 1
230000001755 vocal effect Effects 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
235000008210 xanthophylls Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW092131450A 2002-11-19 2003-11-11 Novel functional peptide nucleic acid and process for producing the same TW200413286A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2002335737A JP2004196662A (ja)	2002-11-19	2002-11-19	新規な機能性ペプチド核酸およびその製法

Publications (1)

Publication Number	Publication Date
TW200413286A true TW200413286A (en)	2004-08-01

Family

ID=32321777

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW092131450A TW200413286A (en)	2002-11-19	2003-11-11	Novel functional peptide nucleic acid and process for producing the same

Country Status (3)

Country	Link
JP (1)	JP2004196662A (ja)
TW (1)	TW200413286A (ja)
WO (1)	WO2004046171A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2010143864A (ja) *	2008-12-19	2010-07-01	Osaka Univ	光応答型アゾベンゼン化合物
CN103408493B (zh) *	2013-07-05	2015-06-03	东南大学	一种多臂萘酰亚胺荧光分子及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1318142T3 (da) *	2000-09-05	2007-08-20	Credia Japan Co Ltd	t-butoxycarbonylaminoethylamin til syntese af PNA-monomerenheder, aminosyrederivater, mellemprodukter deraf og fremgangsmåder til fremstilling af disse
JP4000453B2 (ja) *	2001-09-19	2007-10-31	株式会社クレディアジャパン	新規な機能性ペプチド核酸およびその製法

2002
- 2002-11-19 JP JP2002335737A patent/JP2004196662A/ja active Pending
2003
- 2003-11-11 TW TW092131450A patent/TW200413286A/zh unknown
- 2003-11-17 WO PCT/JP2003/014609 patent/WO2004046171A1/ja not_active Ceased

Also Published As

Publication number	Publication date
JP2004196662A (ja)	2004-07-15
WO2004046171A1 (ja)	2004-06-03

Publication	Publication Date	Title
CA2074135C (fr)	2001-04-17	Procede d'immobilisation d'un fragment d'acide nucleique par fixation passive sur un support solide, support solide ainsi obtenu et son utilisation
Strizhak et al.	2012	Two-color fluorescent l-amino acid mimic of tryptophan for probing peptide–nucleic acid complexes
US20160096867A1 (en)	2016-04-07	CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS
US10851407B2 (en)	2020-12-01	Left-handed gamma-peptide nucleic acids, methods of synthesis and uses therefor
TWI298328B (en)	2008-07-01	Polyamide nucleic acid derivatives, and agents and process for preparing them
US20120322053A1 (en)	2012-12-20	Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens
Seitz et al.	2001	Convergent strategies for the attachment of fluorescing reporter groups to peptide nucleic acids in solution and on solid phase
US9422232B2 (en)	2016-08-23	Reductive release probes containing a chemoselectively cleavable α-azidoether linker and methods of use thereof
Chouikhi et al.	2010	Clickable peptide nucleic acids (cPNA) with tunable affinity
TW200413286A (en)	2004-08-01	Novel functional peptide nucleic acid and process for producing the same
Slaitas et al.	2002	A Novel N‐(Pyrrolidinyl‐2‐methyl) glycine‐Based PNA with a Strong Preference for RNA over DNA
JP3800245B2 (ja)	2006-07-26	新規な機能性ペプチド核酸およびその製法
Bando et al.	2007	Detection of CAG repeat DNA sequences by pyrene-functionalized pyrrole-imidazole polyamides
US6809190B2 (en)	2004-10-26	Functional peptide nucleic acid and its production method
EP2236616B1 (en)	2013-12-18	Peptide nucleic acid probes for analysis of microorganisms
Alleti et al.	2010	A solanesol-derived scaffold for multimerization of bioactive peptides
JP4000453B2 (ja)	2007-10-31	新規な機能性ペプチド核酸およびその製法
TWI290547B (en)	2007-12-01	Novel functional peptide nucleic acid and process for producing the same
CN120504720B (zh)	2026-04-10	一种基于aie效应对组织蛋白酶b响应的生物荧光探针分子的制备方法及其应用
Niedrauer	2020	Part I. A Photolabile Backbone-Amide Linker for Solid-Phase Synthesis of C-Terminally Modified Peptides Part II. Class-II HMG-CoA Reductase Inhibitors For Use as Antimicrobials
Kore	2009	Solid-phase synthesis of new ribo and deoxyribo BrdU probes for labeling and detection of nucleic acids
JP2006204303A (ja)	2006-08-10	新規な機能性ペプチド核酸およびその製法
BHINGARDEVE	2020	Peptide Nucleic Acid (PNA)-GalNAc Conjugates for Targeted Cellular Delivery and C-gama (S/R)-Janus PNAs for Double Duplex Formation with cDNA
Vilaivana et al.	2001	Synthesis and Properties of Novel Peptide Nucleic Acids with Hydrophilic Serine Spacers
WO2001096355A1 (en)	2001-12-20	Nucleoside derivatives